Spermicide clinicals in literature lack modern design standards.
This article was originally published in The Tan Sheet
Executive Summary
SPERMICIDE CLINICAL TRIALS SUFFER FROM LACK OF MODERN DESIGN STANDARDS, execution, analysis and reporting, Princeton University Office of Population Research Director James Trussell, PhD, told a joint meeting of four FDA advisory committees. Trussell presented a review and analysis of the existing data supporting the contraceptive efficacy of spermicides to the Reproductive Health Drugs, Nonprescription Drugs, Anti-Infective Drugs and Antiviral Drugs Advisory Committees at a Nov. 20-22 meeting in Gaithersburg, Md.